390 related articles for article (PubMed ID: 19154763)
1. Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.
Garbayo E; Montero-Menei CN; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
J Control Release; 2009 Apr; 135(2):119-26. PubMed ID: 19154763
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres.
Garbayo E; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2008 Aug; 69(3):844-51. PubMed ID: 18417331
[TBL] [Abstract][Full Text] [Related]
3. Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts.
Clavreul A; Sindji L; Aubert-Pouëssel A; Benoît JP; Menei P; Montero-Menei CN
Eur J Pharm Biopharm; 2006 Jun; 63(2):221-8. PubMed ID: 16497494
[TBL] [Abstract][Full Text] [Related]
4. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
[TBL] [Abstract][Full Text] [Related]
5. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease.
Jollivet C; Aubert-Pouessel A; Clavreul A; Venier-Julienne MC; Montero-Menei CN; Benoit JP; Menei P
Neurosci Lett; 2004 Feb; 356(3):207-10. PubMed ID: 15036631
[TBL] [Abstract][Full Text] [Related]
7. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
[TBL] [Abstract][Full Text] [Related]
8. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
[TBL] [Abstract][Full Text] [Related]
9. Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.
Brizard M; Carcenac C; Bemelmans AP; Feuerstein C; Mallet J; Savasta M
Neurobiol Dis; 2006 Jan; 21(1):90-101. PubMed ID: 16084732
[TBL] [Abstract][Full Text] [Related]
10. In vitro study of GDNF release from biodegradable PLGA microspheres.
Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP
J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
12. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologically active microcarriers releasing glial cell line - derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats.
Tatard VM; Sindji L; Branton JG; Aubert-Pouëssel A; Colleau J; Benoit JP; Montero-Menei CN
Biomaterials; 2007 Apr; 28(11):1978-88. PubMed ID: 17240442
[TBL] [Abstract][Full Text] [Related]
15. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
17. Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor.
Garbayo E; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
Int J Pharm; 2007 Nov; 344(1-2):9-15. PubMed ID: 17499462
[TBL] [Abstract][Full Text] [Related]
18. Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse.
Andrieu-Soler C; Aubert-Pouëssel A; Doat M; Picaud S; Halhal M; Simonutti M; Venier-Julienne MC; Benoit JP; Behar-Cohen F
Mol Vis; 2005 Nov; 11():1002-11. PubMed ID: 16319820
[TBL] [Abstract][Full Text] [Related]
19. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
20. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
